Reading KYMR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track KYMR free→Reading KYMR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track KYMR free→QuarterlyIQ Insights · KYMR
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Jeremy Chadwick communicated his intention to retire and submitted his resignation as Chief Operating Officer (“COO”) on June 5, 2026. Mr. Chadwick will remain an employee of Kymera Therapeutics, Inc. (the “Company”) as an advisor until November 2026. Mr. Chadwick informed the Company that he resigned as COO for personal reasons, and not as the resu…
Importance-ranked changes since the prior daily snapshot.
Signal changed from 'mild_favorable' to 'mixed'.
Company momentum fell by 14.4 points (from 35.4 to 21.0).
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.